During the past decade, Kaiser Permanente Colorado conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Colorado" #1 sponsor was "Kaiser Permanente" with 6 trials, followed by "University of Colorado, Denver" with 6 trials sponsored, "Gilead Sciences" with 4 trials sponsored, "ViiV Healthcare" with 3 trials sponsored and "National Cancer Institute (NCI)" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Colorado" #1 collaborator was "Kaiser Permanente" with 5 trials as a collaborator, "Emory University" with 3 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator and "Pfizer" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Colorado" are "Breast Cancer" (3 trials), "Pregnancy" (3 trials), "Asthma" (2 trials), "Cancer" (2 trials) and "Chronic Lymphocytic Leukemia" (2 trials). Many other conditions were trialed in "Kaiser Permanente Colorado" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Colorado" are "Drug" (14 trials), "Behavioral" (13 trials), "Other" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "MBCT-PD" (2 trials), "8% progesterone vaginal gel" (1 trials), "Allowed third antiretroviral agent" (1 trials), "BKM120" (1 trials) and "BKM120 matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Colorado" are 30 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente Colorado". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Kaiser Permanente Colorado, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Colorado, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".